HugoScore hugoscore.org

Condition-specific coaching and care AI

Twin Health

Twin Health combines sensor-based guidance and clinical care with employer and health-plan contracts. Patient authority when personal goals differ from program cost or medication-reduction goals remains unclear. Current policy documents correction rights and a separate clinical-data notice.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Mixed5 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Mixed 5 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Twin Health AI digital-twin metabolic care program with a clinical team, offered through employer and health plan contracts. Not a standalone patient chatbot.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
The AI digital twin™ shows your metabolism in real-time using data from smart devices Source

The member page and privacy policy call it an 'AI digital twin' and say Twin may use AI technology to process personal information. In-app wording and the telehealth informed consent were not viewed.

2. Operator and model maker namedYesdocumented
Not independently replicated
Our AI digital twin™ technology and clinical care team work together Source

Twin Health, Inc. is named as operator and presents the digital twin as its own technology. The model behind its 'generative AI tool' is not named.

3. Patient chooses to use itNodeployer-dependent
Not independently replicated
A fully covered program through your organization Source

Access is through an employer or plan sponsor and eligibility is set through the sponsor. No source states enrollment is voluntary, although registration requires patient action (Wired describes a member choosing to 'give it a try' when an employer offered it).

4. Patient sets the taskNodocumented
Not independently replicated
Twin gets paid only when users achieve certain clinical outcomes, such as lower blood sugar, weight loss, or the reduction of metabolic medications. Source

Operator and sponsor define the clinical goals and Twin is paid on outcomes. Members choose among recommendations, but the purpose is set by the program.

5. Patient can decline or stopNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

No documented way to decline or stop the AI and keep the same care. Terms say Twin may terminate access, including if a member becomes inactive.

6. Patient sees the AI outputYesdocumented
Not independently replicated
You can see it in your app once you become a member. Source

The member FAQ says the Digital Twin is visible in the app.

7. Patient can correct or challengeNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Members can notify Twin of errors in personal information, but no route to contest AI recommendations is documented.

8. Patient can get a copyYesdocumented
Not independently replicated
You have the right to access your medical records. Source

Terms also give 90 days after termination to retrieve Your Data by emailing [email protected] (commercially reasonable efforts, possible fees).

9. Patient can deleteYesdocumented
Not independently replicated
You may also request for your profile in the App to be deleted. Source

Subject to legal retention. Some information may remain after account deletion.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
Twin Health may use such de-identified data in any lawful manner including for our generative AI tool Source

Privacy policy: normative database of de-identified data used for benchmarking, analysis and its generative AI tool. No patient opt-out documented.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted and sponsor-contracted. No patient route to run it or move the function.

12. No advertising or data businessNodocumented
Not independently replicated
We may further share such aggregate, non-identifiable information with business partners, sponsors and other third parties. Source

The policy also says Twin will not sell personal information and that no information shared within the Services is shared with third-party advertisers. Wired reports employers receive aggregated, anonymized outcome reports.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

MixedEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Mixed, potentially agency-expanding

Legacy editorial placement, pre-method: 58

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does Twin Health serve in this deployment?
Control Twin Health AI digital-twin metabolic care program with a clinical team, offered through employer and health plan contracts. Not a standalone patient chatbot.
Agency read Mixed
Vendor
Twin Health
Who it serves
Hybrid patient-facing digital twin care program
Primary User
Members with metabolic conditions, clinical care teams, employers, and health plans
Control Model
Professional or institution-configured service. Patient controls depend on the deployment.
Patient Impact
Personal data and daily feedback can support reflection. Clinical outcome studies do not establish the ability to inspect a model recommendation or negotiate its objective.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Moderate for program and policy statements (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Legacy editorial placement, pre-method: 58

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 58. Not comparable with v1.3 positions.

Mixed, potentially agency-expanding

Twin Health combines sensor-based guidance and clinical care with employer and health-plan contracts. Patient authority when personal goals differ from program cost or medication-reduction goals remains unclear. Current policy documents correction rights and a separate clinical-data notice.

Patient agency

How this tool changes agency

Expands agency when

Personal data and daily feedback can support reflection. Clinical outcome studies do not establish the ability to inspect a model recommendation or negotiate its objective.

Limits agency when

Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified

Patient agency assessment

Who sets and changes the goal?

Patient authority

Members receive individualized guidance, but the public pages do not establish how they can retain a preferred treatment goal when it differs from program cost or medication-reduction targets.

What can the patient understand, question, or do?

Critical capacity

Personal data and daily feedback can support reflection. Clinical outcome studies do not establish the ability to inspect a model recommendation or negotiate its objective.

Can the patient evaluate the conditions of use?

Informed control

The current policy adds concrete correction rights and a separate clinical-data scope. It does not support a blanket claim that all identifiable health data is shared with employers.

Text findings

Conditions of use

Published controls and their limits

The current policy adds concrete correction rights and a separate clinical-data scope. It does not support a blanket claim that all identifiable health data is shared with employers.

What remains unknown?

Not tested or not established

Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Moderate for program and policy statements (AI-assisted draft)